Could subclinical organ damage markers improve atherosclerotic cardiovascular disease risk assessment in general Chinese population?

Int J Cardiol. 2018 Oct 1:268:229. doi: 10.1016/j.ijcard.2018.03.005.

Authors

Haoyu Wang¹, Shuze Wang², Guozhe Sun¹, Yintao Chen¹, Yingxian Sun³

Affiliations

¹ Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China.
² Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109, USA.
³ Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning 110001, People's Republic of China. Electronic address: sunyingxian1962@163.com.

PMID: 30041792
DOI: 10.1016/j.ijcard.2018.03.005

No abstract available

Keywords: Cardiovascular risk factors; General population; Primary prevention; Risk assessment; Risk score models; Subclinical organ damage.

Publication types

Letter
Comment

MeSH terms

Atherosclerosis*
Biomarkers
Cardiovascular Diseases
Humans
Risk Assessment*
Risk Factors

Substances

Biomarkers